Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.7400
-0.0500 (-6.33%)
May 28, 2026, 4:08 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 456.95 million as of May 28, 2026. Its market cap has decreased by -77.17% in one year.
Market Cap
456.95M
Enterprise Value
771.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.74
Market Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 456.95M, a decrease of -94.10%. That is a compound annual growth rate of -38.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 456.95M | -74.74% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.22B |
| CANbridge Pharmaceuticals | 1.06B |
| Wuhan YZY Biopharma | 1.00B |
| Sunho Biologics | 970.43M |
| 3D Medicines | 866.21M |
| Transcenta Holding | 831.96M |
| Brii Biosciences | 830.08M |
| Shanghai Bio-heart Biological Technology | 827.62M |